Carvedilol vs beta‐blocker
Non‐serious adverse events · adults with cirrhosis and gastroesophageal varices
It is very uncertain whether carvedilol changes non‐serious adverse events compared with traditional, non‐selective beta‐blockers (very low certainty).
1 finding from 1 review
- Carvedilol versus traditional, non‐selective beta‐blockers for adults with cirrhosis and gastroesophageal varices 2018 · Cochrane Headline outcomes onlyRR 0.55 [0.23, 1.29]6 studies · 596 participantsVery low